Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution
- 1 May 2016
- journal article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 31, 77-87
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Nutrition and pancreatic cancer.2014
- Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd 2 (MoO 4 ) 3 mesoporous particlesDalton Transactions, 2013
- Reactive oxygen species mediate tolfenamic acid-induced apoptosis in human colorectal cancer cellsArchives of Biochemistry and Biophysics, 2013
- BREAST CANCER PREVENTION: LIFESTYLE CHANGES AND CHEMOPREVENTION2011
- Curcumin Decreases Survival of Hep3B Liver and MCF-7 Breast Cancer CellsStrahlentherapie und Onkologie, 2011
- Curcumin and its analogues: Potential anticancer agentsMedicinal Research Reviews, 2010
- Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other NutraceuticalsAnnual Review of Nutrition, 2010
- Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.2009
- The case for survivin as a regulator of microtubule dynamics and cell-death decisionsCurrent Opinion in Cell Biology, 2006
- Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer CellsCancer Research, 2004